You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API doxylamine succinate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing doxylamine succinate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Duchesnay USA Inc DICLEGIS doxylamine succinate and pyridoxine hydrochloride 55494-100 ALCOHOL
Duchesnay USA Inc DICLEGIS doxylamine succinate and pyridoxine hydrochloride 55494-100 AMMONIA
Duchesnay USA Inc DICLEGIS doxylamine succinate and pyridoxine hydrochloride 55494-100 BUTYL ALCOHOL
Duchesnay USA Inc DICLEGIS doxylamine succinate and pyridoxine hydrochloride 55494-100 CARNAUBA WAX
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing doxylamine succinate

Company Ingredient NDC Excipient
L Perrigo Company doxylamine succinate 0113-0441 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
L Perrigo Company doxylamine succinate 0113-0441 CELLULOSE, MICROCRYSTALLINE
L Perrigo Company doxylamine succinate 0113-0441 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
L Perrigo Company doxylamine succinate 0113-0441 FD&C BLUE NO. 1
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for doxylamine succinate

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C RED NO. 27

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

doxylamine succinate drug variants containing HYPROMELLOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc doxylamine succinate and pyridoxine hydrochloride 0378-4615
Bryant Ranch Prepack doxylamine succinate and pyridoxine hydrochloride 63629-8358
Bionpharma Inc doxylamine succinate and pyridoxine hydrochloride 69452-206
Par Pharmaceutical Inc doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg 49884-186
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAGNESIUM TRISILICATE

doxylamine succinate drug variants containing MAGNESIUM TRISILICATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc doxylamine succinate and pyridoxine hydrochloride 0378-4615
Actavis Pharma Inc doxylamine succinate and pyridoxine hydrochloride 0591-2132
Par Pharmaceutical Inc doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg 49884-186
Duchesnay USA Inc doxylamine succinate and pyridoxine hydrochloride 55494-100
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

doxylamine succinate drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Mylan Pharmaceuticals Inc doxylamine succinate and pyridoxine hydrochloride 0378-4615
Duchesnay USA Inc doxylamine succinate and pyridoxine hydrochloride 55494-100
Duchesnay USA Inc doxylamine succinate and pyridoxine hydrochloride 55494-120
Bryant Ranch Prepack doxylamine succinate and pyridoxine hydrochloride 63629-8358
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: POLYETHYLENE GLYCOL

doxylamine succinate drug variants containing POLYETHYLENE GLYCOL

Company Ingredient NDC
Mylan Pharmaceuticals Inc doxylamine succinate and pyridoxine hydrochloride 0378-4615
Actavis Pharma Inc doxylamine succinate and pyridoxine hydrochloride 0591-2132
Par Pharmaceutical Inc doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg 49884-186
Bryant Ranch Prepack doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg 63629-2184
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group